Predicting the effect of hepatic disease on systemic drug exposure
{{output}}
Purpose: To employ a comprehensive Top-Down scaling approach to estimate the impact of alterations in bioavailability (gut wall (FG) and hepatic first pass (FH,)) and clearance pathways (renal (ClR) and hepatic (ClH)) on the rela... ...
